Community pharmacy is rapidly redefining its role within primary care, and nowhere is this transformation more visible than in travel health. Once perceived primarily as a provider of routine vaccinations, community pharmacies are now delivering comprehensive, clinically led travel health services - supporting patients before, during, and after international travel.
This evolution represents not only a significant step forward in patient care, but also a critical opportunity for pharmacies to build sustainable, service-led business models.
The backdrop to this transformation is a challenging financial landscape. Community pharmacy in England continues to face a substantial funding gap, estimated at £2.3 billion between the cost of delivering NHS services and the funding received.
With over 2,000 pharmacies having closed since 2015 and uncertainty surrounding the 2026/27 contractual framework, the need to diversify income streams has become increasingly urgent. Travel health and private vaccination services have therefore moved from being optional add-ons to essential components of a resilient pharmacy model.
Modern pharmacy-led travel clinics now offer far more than vaccinations alone. Pharmacists are increasingly undertaking detailed risk assessments and creating personalised travel health plans tailored to the individual, their itinerary, and specific health risks.
This includes protection against diseases such as typhoid, hepatitis A, hepatitis B, dengue, cholera, rabies, Japanese encephalitis, tick-borne encephalitis, and chikungunya, alongside the provision of malaria prophylaxis where required. These consultations reflect a growing level of clinical expertise within the profession, positioning pharmacists as accessible specialists in global health.
Importantly, travel health services also extend to emerging and complex risks. Pharmacists are playing a key role in advising patients on infections such as Zika and Oropouche viruses, particularly for higher-risk groups, including pregnant travellers. At the same time, they continue to address more common but equally significant concerns, such as travellers’ diarrhoea, food- and water-borne infections, and insect bite prevention.
Increasing awareness of drug-resistant sexually transmitted infections has further expanded the scope of pre-travel consultations, reinforcing the need for comprehensive, evidence-based advice.
Alongside clinical services, community pharmacies are uniquely positioned to provide essential travel health products in a single, convenient setting. From first-aid kits and sun protection to insect repellents, mosquito nets and water purification tablets, pharmacies offer a complete “one-stop-shop” approach. This not only improves patient convenience and safety but also creates additional revenue opportunities through linked retail sales.
Within the travel vaccination market, certain services offer particularly strong clinical and commercial value. Yellow fever vaccination is a prime example. Due to international health regulations, only designated centres are authorised to administer the vaccine and issue the official certification required for entry into certain countries.
Pharmacies that achieve this status benefit from a protected service offering, often receiving referrals from GP practices, travel agents, and other healthcare providers. This not only increases patient footfall but also creates opportunities to deliver additional travel vaccines and services within the same consultation.
Similarly, Hajj and Umrah vaccination services provide a reliable and recurring income stream. With meningococcal ACWY vaccination a mandatory requirement for pilgrimage to Saudi Arabia, pharmacies that engage effectively with local communities and travel organisers can establish themselves as trusted providers. These services often act as an entry point for broader travel health consultations, further enhancing both clinical impact and business viability.
Understanding different traveller demographics is essential to maximising the potential of travel health services. Visiting friends and relatives (VFR) travellers represent a particularly important group, often travelling to higher-risk regions and requiring comprehensive vaccination and preventative care. This group frequently generates repeat business, making it both clinically and commercially valuable.
Other key segments include expatriates, students undertaking electives or expeditions, gap year travellers, voluntary workers, and occupational groups such as engineers working overseas. Each presents unique needs and opportunities for tailored service delivery.
Delivering high-quality travel health services requires appropriate infrastructure, training, and workforce engagement. Pharmacies must provide a professional consultation environment that supports private service delivery and builds patient confidence.
Pharmacists must maintain competencies in immunisation, anaphylaxis management, and travel health risk assessment, while staying up to date with evolving global health guidance. The wider pharmacy team also plays a crucial role, from identifying patient opportunities to supporting clinic operations and administration.
Independent prescribing is a key enabler in this space, allowing pharmacists to deliver complete, patient-centred care without reliance on patient group directions. This enhances efficiency, supports clinical autonomy, and enables a more responsive and personalised service.
Marketing and community engagement are equally important. Pharmacies can leverage their trusted position within local communities through in-store promotion, digital channels, and partnerships with travel agents, schools, and employers. There is also growing potential to integrate travel health into broader neighbourhood health models, positioning community pharmacy as a central hub for preventative care.
Ultimately, the expansion of travel health services reflects a wider shift in the role of community pharmacy—from reactive dispensing to proactive, preventative healthcare. In doing so, pharmacies are not only supporting safer international travel but also strengthening their own long-term sustainability.
In an era of financial pressure and increasing healthcare demand, travel health offers a clear path forward. By combining clinical expertise with accessibility and convenience, community pharmacies are well placed to become indispensable partners in global health—delivering safer journeys for patients and a more resilient future for the profession.
(Jignesh Patel is a pharmacist and independent prescriber at CliniLinx )
